Clariane SE (FRA:KO2) Beneish M-Score: -3.03 (As of Jun. 26, 2026)


FRA:KO2 Clariane SE FRA:KO2
60 GF Score
Price €4.14
GF Value €2.46
Valuation Significantly Overvalued
! 9 Warning Signs
View Full Analysis

What is Clariane SE Beneish M-Score?

Clariane SE FRA:KO2 +1.62% 60 Beneish M-Score is -3.03 as of Jun. 26, 2026. GuruFocus rates FRA:KO2 with a GF Score™ of 60/100 and a GF Value™ of €2.46 (Significantly Overvalued). The stock has 9 warning signs investors should review. Among 633 Healthcare Providers & Services companies, Clariane SE ranks better than 79.62% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -3.03 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Clariane SE's Beneish M-Score or its related term are showing as below:

FRA:KO2' s Beneish M-Score Range Over the Past 10 Years
Min: -3.03   Med: -2.56   Max: -2.42
Current: -3.03

During the past 13 years, the highest Beneish M-Score of Clariane SE was -2.42. The lowest was -3.03. And the median was -2.56.


Clariane SE Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Clariane SE's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Clariane SE Beneish M-Score Chart

Clariane SE Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.54 -2.69 -2.42 -2.87 -3.03

Clariane SE Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.42 0.00 -2.87 0.00 -3.03

FRA:KO2 vs HCA, THC, DVA: Beneish M-Score Comparison

For the Medical Care Facilities subindustry, Clariane SE's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Clariane SE Beneish M-Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Clariane SE's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Clariane SE's Beneish M-Score falls into.


FRA:KO2
60GF Score
Clariane SE FRA:KO2
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Clariane SE Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Clariane SE for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.8203+0.528 * 0.9954+0.404 * 0.9909+0.892 * 1.0054+0.115 * 0.8201
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1+4.679 * -0.077541-0.327 * 1.0018
=-3.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec25) TTM:Last Year (Dec24) TTM:
Total Receivables was €675 Mil.
Revenue was €5,310 Mil.
Gross Profit was €4,891 Mil.
Total Current Assets was €1,732 Mil.
Total Assets was €13,807 Mil.
Property, Plant and Equipment(Net PPE) was €6,420 Mil.
Depreciation, Depletion and Amortization(DDA) was €838 Mil.
Selling, General, & Admin. Expense(SGA) was €0 Mil.
Total Current Liabilities was €2,433 Mil.
Long-Term Debt & Capital Lease Obligation was €6,775 Mil.
Net Income was €2 Mil.
Gross Profit was €0 Mil.
Cash Flow from Operations was €1,072 Mil.
Total Receivables was €819 Mil.
Revenue was €5,282 Mil.
Gross Profit was €4,843 Mil.
Total Current Assets was €1,640 Mil.
Total Assets was €14,261 Mil.
Property, Plant and Equipment(Net PPE) was €6,726 Mil.
Depreciation, Depletion and Amortization(DDA) was €704 Mil.
Selling, General, & Admin. Expense(SGA) was €0 Mil.
Total Current Liabilities was €2,907 Mil.
Long-Term Debt & Capital Lease Obligation was €6,587 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(675.416 / 5310.3) / (818.947 / 5281.757)
=0.12719 / 0.155052
=0.8203

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(4842.55 / 5281.757) / (4891.127 / 5310.3)
=0.916845 / 0.921064
=0.9954

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (1731.838 + 6419.606) / 13806.87) / (1 - (1639.556 + 6726.3) / 14260.921)
=0.40961 / 0.413372
=0.9909

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=5310.3 / 5281.757
=1.0054

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(703.806 / (703.806 + 6726.3)) / (838.274 / (838.274 + 6419.606))
=0.094724 / 0.115498
=0.8201

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(0 / 5310.3) / (0 / 5281.757)
=0 / 0
=1

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((6775.03 + 2432.63) / 13806.87) / ((6586.913 + 2906.57) / 14260.921)
=0.66689 / 0.665699
=1.0018

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(1.595 - 0 - 1072.193) / 13806.87
=-0.077541

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Clariane SE has a M-score of -3.03 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -3.03 mean?
Clariane SE (FRA:KO2) has a Beneish M-Score of -3.03 as of Jun. 26, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Clariane SE and its competitors. According to the industry distribution chart, Clariane SE ranks #129 out of 633 companies in the Healthcare Providers & Services industry, placing it in the top 20.4%.
Is Clariane SE's Beneish M-Score too high?
Clariane SE's current Beneish M-Score is -3.03. Based on the distribution chart, Clariane SE ranks #129 out of 633 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Clariane SE has a GF Score™ of 60/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Clariane SE's Beneish M-Score compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Clariane SE ranks #129 out of 633 companies for Beneish M-Score. This places Clariane SE in the top 20% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Healthcare Providers & Services company?
A good Beneish M-Score depends on the Healthcare Providers & Services industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Clariane SE and its competitors. Clariane SE's current Beneish M-Score is -3.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Clariane SE stock overvalued right now?
Based on GuruFocus' analysis, Clariane SE (FRA:KO2) is currently considered Significantly Overvalued. The stock's GF Value™ is €2.46, compared to a current price of €4.14 — trading 68.3% above its estimated fair value. The current Beneish M-Score is -3.03. Clariane SE's overall GF Score™ is 60/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Clariane SE (FRA:KO2), the current Beneish M-Score is -3.03 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Clariane SE (FRA:KO2) Overvalued in 2026?

Based on GuruFocus' analysis, Clariane SE stock appears to be overvalued. The current stock price of €4.14 is trading 68.3% above its estimated GF Value™ of €2.46. GuruFocus considers Clariane SE to be Significantly Overvalued.

Key valuation signals for FRA:KO2:

  • Beneish M-Score: -3.03
  • GF Value™: €2.46 vs. price of €4.14 (68.3% above fair value)
  • GF Score™: 60/100 with 9 warning signs

No single metric tells the full story. See the FRA:KO2 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Clariane SE Business Description

Address 21-25, Rue Balzac, Paris, FRA, 75008
Clariane SE is a specialist in non-acute care and operates in two main areas: long-term care, through two forms of support, medicalized nursing homes offering specialty facilities accommodation and care for vulnerable older people and alternative living solutions, and specialty care activities such as specialty and post-acute , mental health and a number of medical, surgical and obstetrics clinics. Its segments include France, Germany, Benelux, Italy and Spain.
60GF Score

Get the complete analysis for FRA:KO2

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.14
Price
€2.46
GF Value